| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $235,938 | 7 | 39 |
Sells | $54,394,221 | 11 | 61 |
| AGEE NANCY H | director | 3 | $167,643 | 0 | $0 | $167,643 |
| Thomasian Harry Jr. | Chief Financial Officer | 2 | $40,016 | 0 | $0 | $40,016 |
| Tennant Phil | Chief Commercial Officer | 1 | $21,480 | 0 | $0 | $21,480 |
| Shah Rutul R | Chief Operating Officer | 1 | $6,800 | 0 | $0 | $6,800 |
| KINDLER JEFFREY B | director | 0 | $0 | 3 | $1.46M | $-1.46M |
| KIRK RANDAL J | 0 | $0 | 8 | $52.93M | $-52.93M |
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
Over the last 12 months, insiders at Precigen, Inc. have bought $235,938 and sold $54.39M worth of Precigen, Inc. stock.
On average, over the past 5 years, insiders at Precigen, Inc. have bought $9.37M and sold $24.99M worth of stock each year.
Highest buying activity among insiders over the last 12 months: AGEE NANCY H (director) — $167,643. Thomasian Harry Jr. (Chief Financial Officer) — $40,016. Tennant Phil (Chief Commercial Officer) — $21,480.
The last purchase of 6,000 shares for transaction amount of $21,480 was made by Tennant Phil (Chief Commercial Officer) on 2025‑09‑29.
| 2025-12-22 | Sale | KIRK RANDAL J | 1.88M 0.5985% | $4.18 | $7.88M | +1.20% | ||
| 2025-12-22 | Sale | KIRK RANDAL J | 1.9M 0.6036% | $4.18 | $7.94M | +1.20% | ||
| 2025-12-12 | Sale | KINDLER JEFFREY B | director | 235,467 0.0769% | $3.63 | $855,899 | +19.24% | |
| 2025-11-21 | Sale | KIRK RANDAL J | 937,308 0.308% | $3.83 | $3.59M | +7.86% | ||
| 2025-11-20 | Sale | KIRK RANDAL J | 942,832 0.3283% | $4.08 | $3.85M | +7.18% | ||
| 2025-11-19 | Sale | KIRK RANDAL J | 1.09M 0.383% | $4.47 | $4.86M | -0.95% | ||
| 2025-09-30 | Sale | KIRK RANDAL J | 1.81M 0.6309% | $3.41 | $6.17M | +23.56% | ||
| 2025-09-30 | Sale | KINDLER JEFFREY B | director | 106,837 0.0369% | $3.38 | $361,109 | +23.56% | |
| 2025-09-29 | Sale | KINDLER JEFFREY B | director | 67,523 0.0225% | $3.60 | $243,083 | +11.85% | |
| 2025-09-29 | Tennant Phil | Chief Commercial Officer | 6,000 0.002% | $3.58 | $21,480 | +11.85% | ||
| 2025-09-26 | Thomasian Harry Jr. | Chief Financial Officer | 2,932 0.001% | $3.42 | $10,027 | +15.53% | ||
| 2025-09-26 | Shah Rutul R | Chief Operating Officer | 2,000 0.0007% | $3.40 | $6,800 | +15.53% | ||
| 2025-09-25 | Thomasian Harry Jr. | Chief Financial Officer | 8,284 0.0026% | $3.62 | $29,988 | +16.05% | ||
| 2025-09-19 | Sale | KIRK RANDAL J | 3.6M 1.1874% | $3.68 | $13.24M | +7.47% | ||
| 2025-09-18 | Sale | KIRK RANDAL J | 1.4M 0.4784% | $3.86 | $5.42M | +5.92% | ||
| 2025-09-04 | AGEE NANCY H | director | 15,000 0.0051% | $4.60 | $69,000 | -11.73% | ||
| 2025-08-28 | AGEE NANCY H | director | 10,645 0.0037% | $4.65 | $49,491 | -11.15% | ||
| 2025-08-19 | AGEE NANCY H | director | 15,360 0.0051% | $3.20 | $49,152 | +25.78% | ||
| 2024-08-09 | KIRK RANDAL J | 23.53M 7.203% | $0.85 | $20M | +20.91% | |||
| 2024-08-09 | Perez Jeffrey Thomas | SVP, IP Affairs | 58,823 0.018% | $0.85 | $50,000 | +20.91% |
| Thomasian Harry Jr. | Chief Financial Officer | 468626 0.156% | $1.56M | 5 | 5 | <0.0001% |
| Shah Rutul R | Chief Operating Officer | 405959 0.1351% | $1.35M | 2 | 4 | <0.0001% |
| KIRK RANDAL J | 341189 0.1136% | $1.13M | 70 | 20 | +6.88% | |
| AGEE NANCY H | director | 217841 0.0725% | $723,232.12 | 3 | 0 | |
| KINDLER JEFFREY B | director | 110603 0.0368% | $367,201.96 | 2 | 5 | <0.0001% |
| Tennant Phil | Chief Commercial Officer | 65031 0.0216% | $215,902.92 | 1 | 0 | |
| Ares Trading S.A. | 10 percent owner | 20647152 6.8726% | $68.55M | 1 | 67 | +52.74% |
| Sabzevari Helen | President and CEO | 1560004 0.5193% | $5.18M | 1 | 23 | <0.0001% |
| Frank Steven | director | 882358 0.2937% | $2.93M | 1 | 0 | <0.0001% |
| Hassan Fred | director | 878942 0.2926% | $2.92M | 2 | 0 | <0.0001% |
| Perez Jeffrey Thomas | SVP, IP Affairs | 743097 0.2473% | $2.47M | 3 | 20 | <0.0001% |
| Lehr Donald P. | Chief Legal Officer | 428916 0.1428% | $1.42M | 2 | 21 | +21.62% |
| MITCHELL DEAN J | director | 356836 0.1188% | $1.18M | 2 | 0 | <0.0001% |
| Sterling Rick L. | Chief Financial Officer | 340020 0.1132% | $1.13M | 0 | 13 | |
| Reed Thomas D. | Chief Science Officer | 148888 0.0496% | $494,308.16 | 2 | 9 | +21.52% |
| Frost Gregory Ian | SVP--Health Sector | 100000 0.0333% | $332,000.00 | 3 | 0 | <0.0001% |
| LIFFMAN JOEL D | SVP, Finance | 85541 0.0285% | $283,996.12 | 1 | 2 | <0.0001% |
| SHAPIRO ROBERT B | director | 82966 0.0276% | $275,447.12 | 2 | 0 | <0.0001% |
| Bostick Thomas | Chief Operating Officer | 74280 0.0247% | $246,609.60 | 0 | 5 | |
| Krishnan Krish S | Chief Operating Officer | 42000 0.014% | $139,440.00 | 1 | 2 | +59.01% |
| Krishnan Suma | SVP--Product Development | 42000 0.014% | $139,440.00 | 1 | 2 | +59.01% |
| Walsh Robert F. III | SVP, Energy & Fine Chem. | 28816 0.0096% | $95,669.12 | 0 | 2 | |
| Kasser Thomas R. | SVP--Food Sector | 15000 0.005% | $49,800.00 | 2 | 0 | +19.61% |
| Nimrodi Nir | Chief Business Officer | 5708 0.0019% | $18,950.56 | 2 | 1 | <0.0001% |
| Last Andrew J. | Chief Operating Officer | 4000 0.0013% | $13,280.00 | 2 | 0 | +0.56% |
| Huang Kelly | SVP-Consumer Sector | 3200 0.0011% | $10,624.00 | 1 | 0 | +59.01% |
| Gupta Vinita D | director | 3000 0.001% | $9,960.00 | 1 | 0 | <0.0001% |
Precigen, Inc. (PGEN) | $607,159,124 | 92 | 3.55% | $997.42M |
$14,874,415 | 78 | 37.43% | $1.07B | |
$61,783,526 | 37 | 18.57% | $964.02M | |
$35,092,436 | 31 | 38.62% | $959.26M | |
$150,336,897 | 29 | -5.97% | $1.05B | |
$105,195,330 | 29 | 14.02% | $1.05B | |
$21,945,105 | 15 | -26.51% | $1.09B | |
$48,220,484 | 14 | 2.13% | $1.01B | |
$133,809,976 | 13 | 31.29% | $873.45M | |
$49,967,154 | 11 | 62.08% | $1.15B | |
$1,435,760 | 10 | 2.01% | $976.68M | |
$5,794,001 | 10 | 23.26% | $975.36M | |
$1,580,951 | 9 | -14.18% | $957.71M | |
$38,624,786 | 9 | 1.26% | $929.86M | |
$21,792,890 | 6 | 75.72% | $895.57M | |
$1,944,616 | 6 | 0.35% | $1.06B | |
$41,260,462 | 6 | -1.36% | $1B | |
$33,624,000 | 2 | -50.37% | $1.01B | |
$504,640 | 1 | 16.84% | $898.53M |
| Increased Positions | 114 | +79.72% | 47M | +42.1% |
| Decreased Positions | 56 | -39.16% | 21M | -19.22% |
| New Positions | 38 | New | 6M | New |
| Sold Out Positions | 20 | Sold Out | 4M | Sold Out |
| Total Postitions | 201 | +40.56% | 137M | +22.88% |
| Patient Capital Management, Llc | $113,252.00 | 7.48% | 26.46M | +10M | +62.65% | 2025-09-30 |
| Tang Capital Management Llc | $53,072.00 | 3.5% | 12.4M | +12M | New | 2025-09-30 |
| Blackrock, Inc. | $52,002.00 | 3.43% | 12.15M | +1M | +9.01% | 2025-09-30 |
| Vanguard Group Inc | $38,273.00 | 2.53% | 8.94M | -127,744 | -1.41% | 2025-09-30 |
| State Street Corp | $19,216.00 | 1.27% | 4.49M | +1M | +48.22% | 2025-09-30 |
| Geode Capital Management, Llc | $16,473.00 | 1.09% | 3.85M | +99,556 | +2.65% | 2025-09-30 |
| Iridian Asset Management Llc/Ct | $15,695.00 | 1.04% | 3.67M | -611,716 | -14.3% | 2025-09-30 |
| Point72 Asset Management, L.P. | $11,732.00 | 0.77% | 2.74M | +3M | New | 2025-09-30 |
| Occam Crest Management Lp | $11,545.00 | 0.76% | 2.7M | +3M | New | 2025-09-30 |
| Citadel Advisors Llc | $11,538.00 | 0.76% | 2.7M | +2M | +756.35% | 2025-09-30 |